baber/WOPTO huggingface dataset:
Patent WO-2021011695-A1 (WO)
Inventor: LEGALLAIS YVON
IPC: H04N13/161
Filed: 2020-07-15
Abstract: The disclosure discloses methods and devices for transmitting and rendering a 3D scene. The method for transmitting comprises: segmenting a space into m angular sectors, the m angular sectors each corresponding to an angular distance from a viewport, and the space into n depth ranges; obtaining (11) at least one first patch, generated from a first view of the 3D scene, said at least one first patch comprising a texture component and a depth component; obtaining (12) at least one atlas, generated from at least one second view of the 3D scene, said at least one atlas being built by packing together at least one second patch generated for at least one point of one of said second view that is not visible in another view of the 3D scene and that belongs to a same angular sector among the m angular sectors, and a same depth range among the n depth ranges, at least one of m or n being greater than or equal to 2, said at least one second patch comprising a texture component and a depth component, wherein each of the at least one first patch and the at least one second patch is based on at least one of a sector and a depth; generating (13) a first subset of streams comprising m' pairs of streams and a second subset of streams comprising m' x n' pairs of streams; and transmitting (14) the first and second subsets of streams to the terminal.
Patent WO-2021025883-A1 (WO)
Title: Gestionnaire de câble horizontal à porte articulée
Inventor: O'YOUNG JASON
IPC: H04Q1/06
Filed: 2020-07-27
Abstract: Gestionnaire de câble horizontal connecté à un bâti de réseau qui achemine des câbles à l'intérieur et aux environs de celui-ci. Le gestionnaire de câble horizontal comprend un corps doté d'un arrière et une pluralité de doigts s'étendant à partir de l'arrière du corps. L'extrémité distale d'au moins un doigt comprend un support de broche de charnière. Le gestionnaire de câble horizontal comprend également une porte fixée de manière articulée aux doigts s'étendant à partir du corps. La porte présente un bord avant, un bord arrière, un bord supérieur, un bord inférieur et au moins un réceptacle de broche de charnière positionné le long du bord supérieur ou du bord inférieur de la porte. Le réceptacle de broche de charnière loge un aimant pour permettre à la porte de se fixer au support de broche de charnière du ou des doigts pour maintenir la porte dans une position fermée.
Patent WO-2021022110-A1 (WO)
Title: Induction d'effets immunitaires à l'aide de bactéries du genre bifidobacterium
Inventor: ARGUETA SHANNON
IPC: A61P35/00
Filed: 2020-07-31
Abstract: L'invention concerne des procédés et des compositions associés à l'induction d'un ou plusieurs des effets immunitaires décrits par administration orale d'une composition pharmaceutique contenant des bactéries du genre Bifidobacterium.
Patent WO-2021035188-A1 (WO)
Title: Novel il-21 prodrugs and methods of use thereof
Inventor: LU YUEFENG
IPC: C07K19/00
Filed: 2020-08-21
Abstract: Provided herein are IL-21 prodrugs and methods of making and using thereof for stimulating the immune system, or treating cancer or an infectious disease.
Patent WO-2021041958-A1 (WO)
Inventor: SCHREIBER TAYLOR
IPC: C12N15/62
Filed: 2020-08-28
Abstract: The present invention relates, inter alia, to compositions and methods, including chimeric proteins having a first domain comprising an extracellular domain of a first transmembrane protein, a first secreted protein, or a first membrane- anchored extracellular protein and a second domain comprising an extracellular domain of a second transmembrane protein, a second secreted protein, or a second membrane-anchored extracellular protein, in which either or both of the first domain and the second domain decreases self-directed immune system activity when bound to its ligand/receptor. Accordingly, the present invention find use in the treatment of autoimmune diseases.
Patent WO-2021050337-A1 (WO)
Title: Integrated access and backhaul from high altitude platforms
Inventor: ANANTH SHARATH
IPC: H04W76/10
Filed: 2020-09-02
Abstract: A method is for establishing one or more links for an integrated access and backhaul for millimeter wave network. The network includes a high-altitude platform (HAP) (114) as a first node and a terrestrial node (110) as a second node. The method includes obtaining (402) location information of the HAP in the network, determining (404) that the HAP can be used to provide an additional access link or an additional backhaul link in the network in connection with the terrestrial node, controlling (406) one or more transceivers of the terrestrial node to point towards the HAP according to the location information, and establishing (408) the additional access link or the additional backhaul link between the HAP and the terrestrial node.
Patent WO-2021046331-A1 (WO)
Title: Anti-steap1 antibodies and uses thereof
Inventor: CHEUNG NAI-KONG V
IPC: C07K16/28
Filed: 2020-09-04
Abstract: The present technology relates generally to the preparation of immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that specifically bind STEAP1 protein and uses of the same. In particular, the present technology relates to the preparation of STEAP1 binding antibodies and their use in detecting and treating STEAP1 -associated cancers.
Patent WO-2021055876-A1 (WO)
Inventor: ORTIZ DANIEL
IPC: C07K16/28
Filed: 2020-09-18
Abstract: L'invention concerne des constructions de liaison à l'antigène Fc ayant un domaine de liaison à CD38 et au moins deux domaines Fc, ainsi que des procédés d'utilisation de telles constructions. L'invention concerne également des polypeptides constituant de telles constructions. Les monomères de domaine Fc qui sont inclus dans les constructions peuvent comprendre des substitutions d'acides aminés qui favorisent l'homodimérisation ou l'hétérodimérisation.
Patent WO-2021076280-A1 (WO)
Inventor: BURDETTE STEVEN ROY
IPC: B60R11/02
Filed: 2020-09-23
Abstract: Emobidments of a curved display assembly are disclosed. The assembly includes a glass sheet having first and second major surfaces. The second major surface defines a first curvature of the glass sheet, and the first curvature has a bend axis. The assembly also includes a curved display having a second thickness between first and second display surfaces. The display has a display region and two overhanging edges adjacent to the display region and parallel to the bend axis. A first adhesive bonds the second display surface to the second major surface in the display region. A second adhesive is disposed between each of the two overhanging edges and the second major surface. The second adhesive has a higher elastic modulus than the first adhesive. The overhanging edges each extend a distance outside of the display area that is at least three times the second thickness of the curved display.
Patent WO-2021061752-A1 (WO)
Title: Pharmaceutical compositions comprising poh derivatives
Inventor: CHEN THOMAS
IPC: C07K16/28
Filed: 2020-09-23
Abstract: The present invention provides for a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative. For example, the perillyl alcohol derivative may be a perillyl alcohol carbamate. The perillyl alcohol derivative may be perillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The present invention also provides for a method of treating a disease such as a primary cutaneous lymphoma which may be a cutaneous T cell lymphoma (CTCL). The CTCL may be mycosis fungoides, primary cutaneous anaplastic large cell lymphoma (ALCL), or Sezary syndrome. A patient may be administered a therapeutically effective amount of a derivative of monoterpene (or sesquiterpene).
Patent WO-2021067613-A1 (WO)
Inventor: BIFFI ALESSANDRA
IPC: C12N15/79
Filed: 2020-10-01
Abstract: The present disclosure features methods and compositions for treating amyotrophic lateral sclerosis (ALS). The disclosed methods comprise administering to a subject having or suspected of having ALS a hematopoietic stem progenitor cell expressing at least one neuroprotective agent. The compositions disclosed comprise hematopoietic stem progenitor cells transduced to express a neuroprotective agent.
Patent WO-2021067806-A1 (WO)
Inventor: PLAKOGIANNIS FOTIOS M
IPC: A61K9/00
Filed: 2020-10-02
Abstract: Provided is a transdermal drug delivery system comprising dronabinol. The dronabinol transdermal delivery system provides a drug plasma concentration at predetermined rate for a predetermined period of time, offering a simplified therapeutic regimen by decreasing dosing frequency for the treatment and/or prevention of nausea and/or vomiting associated with, for example, chemotherapy.
Patent WO-2021071792-A1 (WO)
Title: Particle detectors with remote alarm monitoring and control
Inventor: MACLAUGHLIN SCOTT
IPC: H04N5/44
Filed: 2020-10-06
Abstract: The invention generally provides devices and methods for particle detection for minimizing human-caused contamination in manufacturing environments requiring low levels of microbes, such as cleanroom environments for electronics manufacturing and aseptic environments for manufacturing pharmaceutical and biological products, such as sterile medicinal products. Methods of the invention may incorporate wirelessly transmitting an alarm signal from a particle detector to a remote device, replicating a graphical user interface of the particle detector on an electronic display of the remote device, and passing one or more user instructions from the remote device to the particle detector via the replicate graphical interface of the remote device
Patent WO-2021076382-A1 (WO)
Inventor: BURKE-AGUERO REBECCA
IPC: H04L9/32
Filed: 2020-10-08
Abstract: Described herein is a system and method for validating media integrity using asymmetric key cryptography utilizing a public/private cryptographic key pair. The private key is kept secret and is known to an originator and/or publisher of a media file. The public key is added to the media file and is used to validate integrity of the media file, that is, that content of the media file (e.g., portion(s), frame(s)) has not been altered since publication of the media file. By validating integrity of the media file, strong proof that the media file came from an owner of the keypair (e.g., had possession of the private key) can be obtained, for example, resolving issues of trust and/or authenticity common in altered content. In some embodiments, information regarding an origin of the content can further be determined.
Patent WO-2021072149-A1 (WO)
Title: Systems and methods for monitoring fluid volumes during peritoneal dialysis
Inventor: KOTANKO PETER
IPC: A61M1/00
Filed: 2020-10-09
Abstract: Techniques for monitoring fluid volumes during peritoneal analysis include: computing lower abdominal fluid volumes, continuously during a dwell time of a peritoneal dialysis treatment, based at least on bioimpedance data from electrodes positioned on a patient's upper thighs; and computing intraperitoneal volumes, continuously during the dwell time of the peritoneal dialysis treatment, based at least on bioimpedance data from the electrodes positioned on the patient's upper thighs and electrodes positioned on the patient's torso.
Patent WO-2021086597-A1 (WO)
Inventor: CHEN MARK
IPC: G06Q20/00
Filed: 2020-10-13
Abstract: Proxied cross-ledger authentication techniques are disclosed. In various embodiments, a verifier presentation requirement is determined, the verifier presentation requirement indicating a set of elements required to be provided by a client to authenticate the client. An authentication contract instance is created on a market maker ledger not associated specifically with the verifier, the authentication contract instance including at least a subset of the elements required by the verifier presentation requirement. A verifier system associated with the verifier presentation requirement is configured to read information from the authentication contract instance, obtain from an issuer associated with the client an issuer revocation data associated with the authentication contract instance, and use the information read from the authentication contract instance and the issuer revocation data to authenticate the client.
Patent WO-2021086720-A1 (WO)
Title: Methods and apparatus for automated specimen characterization using diagnostic analysis system with continuous performance based training
Inventor: NARASIMHAMURTHY VENKATESH
IPC: A61B5/00
Filed: 2020-10-22
Abstract: A method of characterizing a specimen to be analyzed in an automated diagnostic analysis system provides a segmentation determination and/or an HILN (hemolysis, icterus, lipemia, normal) determination of the specimen while providing characterization training updates based on the accuracy and/or confidence in the determinations. The method includes identifying an incorrect or low confidence segmentation or HILN determination, forwarding the incorrect or low confidence determination from the HILN network to a database, and providing one or more training images to the HILN network based on the incorrect or low confidence determination. Quality check modules and systems configured to carry out the method are also described, as are other aspects.
Patent WO-2022098361-A1 (WO)
Inventor: GIANCHANDANI YOGESH B
IPC: F16L55/26
Filed: 2020-11-06
Abstract: Selon divers aspects, la présente invention concerne un exemple de microsystème autonome destiné à être immergé dans un fluide. Le microsystème autonome comprend de l'électronique, une source d'énergie et un système d'emballage qui entoure l'électronique et la source d'énergie. L'électronique peut être conçue pour détecter et enregistrer une ou plusieurs conditions environnementales. Le système d'emballage peut comprendre une coque déformable qui définit un espace interne et une pluralité de particules de charge disposées dans l'espace interne et conçues pour réguler une densité du microsystème autonome par rapport au fluide. Les particules de charge peuvent comprendre un matériau de faible densité ayant une masse volumique apparente égale ou supérieure à environ 100 kg/m3 et inférieure ou égale à environ 1 000 kg/m3 et ont une densité d'emballage égale ou supérieure à environ 1011/m3 et inférieure ou égale à environ 1021/m3.
Patent WO-2021133477-A1 (WO)
Title: Système et procédé de détection de transactions bancaires frauduleuses
Inventor: POST RICHARD ALLEN
IPC: G06Q20/10
Filed: 2020-11-09
Abstract: L'objet divulgué se rapporte à un système de détection d'une transaction de GAB frauduleuse. Le système concerne une machine de GAB qui reçoit une carte bancaire/de GAB en provenance d'un client. Le GAB tente d'abord de lire des informations à partir de la puce de carte, mais ne peut pas le faire en raison d'une erreur de lecture. Le GAB lit ensuite les informations à partir de la bande magnétique, et déclenche une procédure de détection de fraude. Selon cette première sorte de procédure, le GAB utilise un point d'accès sans fil local pour détecter un dispositif client, tel qu'un téléphone, à proximité du GAB. Selon une autre sorte de procédure, le GAB communique avec un serveur principal. Le serveur principal détermine ensuite l'emplacement du dispositif client soit en transmettant un message de demande d'autorisation, soit en utilisant un GPS ou un autre moyen de détection d'emplacement sur le dispositif client pour déterminer si le dispositif client se trouve à proximité du GAB.
Patent WO-2021097084-A1 (WO)
Title: Methods for treating immunosuppression and diseases associated with immunosuppression
Inventor: ZMIJEWSKI JAROSLAW
IPC: A61K39/00
Filed: 2020-11-12
Abstract: Peptides are provided for the treatment of various diseases and conditions, including infection, sepsis, and trauma as well as immunosuppression resulting from infection, sepsis and/or trauma. Methods of treating an infection, neutrophil dysfunction, sepsis, trauma, immunosuppression associated with infection, sepsis and/or trauma, organ injury associated with any of the foregoing (such as, but not limited to, ARDS, lung fibrosis, IPF, and COPD), or a symptom of any of the foregoing comprising administering a disclosed peptide are also provided as well as pharmaceutical compositions and kits comprising a disclosed peptide.
Patent WO-2021108512-A1 (WO)
Inventor: XU PIN-XIAN
IPC: C12N15/86
Filed: 2020-11-25
Abstract: Provided herein are compositions and methods for treating and preventing hearing loss, for treating and preventing a disorder associated with loss, damage, or absence of sensory auditory hair cells, and/or for improving auditory function in a subject in need thereof. Also provided are compositions and methods for the generation of auditory hair cells that allow perception of stimuli in a subject in need thereof.
Patent WO-2021119215-A1 (WO)
Inventor: CHATTOPADHYAY SHRIKANTA
IPC: A61K45/06
Filed: 2020-12-09
Abstract: Disclosed herein are methods and compositions for inhibiting Aldh3a2 expression and activity to improve leukemia outcomes. Aldh3a2 depletion results in an iron-dependent oxidative cell death of leukemia cells while sparing normal hematopoiesis.
Patent WO-2022139809-A1 (WO)
Inventor: QUARTO DANIEL ETHAN FRANTZ
IPC: C12M3/00
Filed: 2020-12-22
Abstract: An example device comprises: a carriage to receive a cassette holding a sample preparation cartridge module. The carriage comprises: a cassette constrainer portion; and a cassette holder portion. The holder portion is to: receive the cassette; and move, relative to the constrainer portion, between a cassette receiving position and a cassette constraining position. The constrainer portion comprises: a first locating feature and a second locating feature. The first locating feature is to: mate with a corresponding first locating feature of the sample preparation cartridge module to position the second locating feature relative to a corresponding second locating feature of the sample preparation cartridge module. The second locating feature is to: mate with the corresponding second locating feature of the sample preparation cartridge module to constrain movement of the sample preparation cartridge module relative to the carriage, when the cassette holder portion is pivoted to the cassette constraining position.
Patent WO-2021138359-A1 (WO)
Title: Expanding polyurethane foam and methods and systems for using same
Inventor: ORF NICHOLAS
IPC: C08G18/18
Filed: 2020-12-29
Abstract: The present disclosure relates generally to methods, devices and systems for insulation, e.g., of cavities associated with walls, ceilings, floors and other building structures, with foam insulation. In one aspect, the disclosure provides a method for providing a cavity of a building with an expanded foam insulation. The method includes dispensing an amount of an expanding foam insulation into the cavity, the expanding foam insulation being dispensable and expandable to provide the expanded foam insulation material, the expanding foam insulation material formed from a premix comprising at least one polyol, at least one polyisocyanate, a blowing agent, and an encapsulated catalyst, the encapsulated catalyst comprising a plurality of catalyst capsules, each comprising an amount of catalyst and a capsule shell encapsulating the catalyst, wherein the dispensing is performed to apply a force to the encapsulated catalyst sufficient to break capsules and release catalyst, the released catalyst initiating reaction between the at least one polyol and the at least one isocyanate; and then allowing the dispensed amount of expanding foam insulation to substantially finish expanding after it is dispensed in the cavity, thereby forming the expanded foam insulation in the cavity.
Patent WO-2020264573-A1 (WO)
Inventor: WEI KARL
IPC: A61K8/44
Filed: 2020-06-26
Abstract: L'invention concerne un produit d'hygiène personnelle hydrosoluble comprenant une structure fibreuse hydrosoluble ; la structure fibreuse hydrosoluble comprenant une pluralité d'éléments fibreux ; la pluralité d'éléments fibreux comprenant un ou plusieurs matériaux formant des éléments fibreux comprenant un ou plusieurs alcools polyvinyliques ; et un ou plusieurs agents actifs présents dans la pluralité d'éléments fibreux, le ou les agents actifs comprenant un ou plusieurs tensioactifs, le ou les tensioactifs comprenant au moins un tensioactif de glutamate selon la formule générale (I) : (I) R1 représentant une chaîne alkyle ou alcényle linéaire ou ramifiée, saturée ou insaturée ayant de 5 à 20 atomes de carbone ; et M étant H, de l'ammonium, du triéthanolammonium (TEA), du sodium ou du potassium et des mélanges de ceux-ci ; et la structure fibreuse hydrosoluble étant sensiblement exempte de tensioactifs de type sulfate d'alkyle et sulfate d'éther d'alkyle.
Patent WO-2022039787-A1 (WO)
Inventor: HEJZLAR PAVEL
IPC: G21C1/03
Filed: 2021-03-04
Abstract: A nuclear reactor is configured with an intermediate coolant loop for transferring thermal energy from the reactor core for a useful purpose. The intermediate coolant loop includes a bypass flowpath with an air heat exchanger for dumping reactor heat during startup and/or shutdown. A fluidic diode along the bypass flowpath asymmetrically restricts flow across the bypass flowpath, inhibiting flow in a first flow direction during a full power operating condition and allowing a relatively uninhibited flow in a second direction during a startup and/or shut down low power operating condition.
Patent WO-2021188941-A1 (WO)
Title: Methods of isolating t cells and t-cell receptors from peripheral blood by single-cell analysis for immunotherapy
Inventor: YOSEPH RAMI
IPC: A61K39/00
Filed: 2021-03-19
Abstract: Provided are methods of preparing an enriched population of T cells having antigenic specificity for a target antigen. The method may comprise isolating T cells from a blood sample of a patient; selecting the isolated T cells which have a gene expression profile; and separating the selected T cells from the unselected cells. The separated selected T cells provide an enriched population of T cells having antigenic specificity for the target antigen. Methods of isolating a TCR, preparing a population of cells that express a TCR, isolated TCRs, isolated populations of cells, pharmaceutical compositions, and methods of treating or preventing a condition in a mammal are also provided.
Patent WO-2022203672-A1 (WO)
Title: Système de forage avec système de détection de gaz destiné à être utilisé dans le forage d'un puits
Inventor: ROWE MATHEW DENNIS
IPC: E21B47/12
Filed: 2021-03-25
Abstract: L'invention concerne un système de forage pour forer un puits. Le système de forage peut comprendre un train de tiges de forage, un détecteur de gaz et un système informatique. Le train de tiges de forage peut comprendre un moteur de fond de trou utilisable pour faire tourner un trépan et le moteur de fond de trou peut comprendre un stator et un rotor, le stator ou le rotor comprenant un composé élastomère. Le détecteur de gaz peut être utilisable pour détecter un gaz indiquant la détérioration du composé élastomère. Le système informatique peut être programmé pour générer une indication sur la base de la détection du gaz indiquant la détérioration par le détecteur de gaz.
Patent WO-2021195317-A1 (WO)
Inventor: HOGAN MICHAEL
IPC: C12Q1/6809
Filed: 2021-03-25
Abstract: Provided herein is a method for detecting the presence of a COVID-19 virus in a human sample or an environmental sample having one or more viral and bacterial pathogens. Samples processed to obtain total nucleic acids. The nucleic acids are used as a template in a reverse transcription-amplification reaction to obtain cDNA, which is used in a PCR amplification reaction to obtain fluorescent COVID-19 virus specific amplicons. These amplicons are detected by microarray hybridization near the lowest limit of detection. Also provided is a method for detecting in addition to the COVID-19 virus, the presence of respiratory disease-causing pathogens including viruses, bacteria and fungus in a single assay using the above method.